We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

3 hedge funds and large institutions have $2.56M invested in Seelos Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

66% less capital invested

Capital invested by funds: $7.61M → $2.56M (-$5.05M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$468K
2
HVC
Healthcare Value Capital
New Jersey
-$149K
3
Northern Trust
Northern Trust
Illinois
-$23K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$21K
5
GC
Guggenheim Capital
Illinois
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$1.88M – – –
AFM
2
Anson Funds Management
Texas
$263K -$468K -2 -50%
Vanguard Group
3
Vanguard Group
Pennsylvania
$206K – – –
Franklin Resources
4
Franklin Resources
California
$41K – – –
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$34K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$33K – – –
AIM
7
Acrospire Investment Management
Illinois
$21K – – –
ARTA
8
A.R.T. Advisors
New York
$19K – – –
VKH
9
Virtu KCG Holdings
New York
$18K – – –
RJFSA
10
Raymond James Financial Services Advisors
Florida
$14K – – –
BIT
11
BlackRock Institutional Trust
California
$8K – – –
IP
12
Intellectus Partners
California
$4K – – –
EWM
13
Evercore Wealth Management
New York
$3K – – –
MFS
14
MSI Financial Services
Massachusetts
$3K – – –
Wells Fargo
15
Wells Fargo
California
$3K – – –
BA
16
BlackRock Advisors
Delaware
$2K – – –
BFA
17
BlackRock Fund Advisors
California
$2K – – –
Group One Trading
18
Group One Trading
Illinois
$2K – – –
AG
19
Advisor Group
Arizona
$1K – – –
Bank of America
20
Bank of America
North Carolina
$1K – – –
Creative Planning
21
Creative Planning
Kansas
$1K – – –
FANJ
22
Financial Architects (New Jersey)
New Jersey
$1K – – –
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
Morgan Stanley
24
Morgan Stanley
New York
$1K – – –
Bank of New York Mellon
25
Bank of New York Mellon
New York
– -$21K – –
1
2

SEEL Hedge Fund Activity: Q4 2016 in Review

3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q4 2016, worth a combined $2.56M — down 66% from $7.61M a quarter earlier.

Fund positioning in SEEL was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Anson Funds Management, cutting an estimated $468K.

  • 3 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $2.56M of Seelos Therapeutics, Inc. Common Stock stock for Q4 2016, down 66% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q4 2016 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q4 2016 was Anson Funds Management, an estimated $468K sold.

Based on aggregated 13F filings for Q4 2016.